arXiv paper· medical imaging AI (dermatology, computer vision)· empirical study

Disease Burden over Skin Tone: Decomposing the Dermatology-AI Generalization Gap

Nirajan Kunwor, Sanjaya Poudel, Quoc-Huy Trinh, Jahidul Arafat, Sunil Kumar Gaire

cs.CV · cs.AI · cs.LG

Quick verdict

Argues disease shift, not skin tone, dominates dermatology-AI failure; an honest, careful frozen-feature study, though its decomposition is only suggestive.

Summary

The paper asks whether dermatology AI's poor generalization to resource-constrained settings stems mainly from skin-tone underrepresentation or disease-distribution shift. Four frozen encoders — a ResNet-50 cancer baseline fine-tuned on HAM10000+ISIC 2019, dermatology foundation models DermLIP and MONET, and DINOv3 — are probed on DDI (tone-stratified, binary malignant/benign) to isolate the tone effect and on SCIN (tone-diverse, non-neoplastic, seven clinical categories) to isolate the distribution effect. The cancer baseline falls from 0.62 balanced accuracy in-domain to 0.21 on SCIN, while DDI tone gaps are 0.10–0.18 with wide bootstrap CIs and no consistent direction. A label-free kNN purity analysis (k=10, cosine, lift over a chance floor) shows the collapse is representational: the cancer baseline drops from +0.42 purity lift in-domain to +0.06 on SCIN, versus +0.23 for DermLIP. Few-shot probes with ten labeled examples per category nearly match full probes for the foundation models (DermLIP 0.41 vs 0.36), and SCIN purity lift correlates with recoverable accuracy (r=0.90, n=4, descriptive). The authors candidly flag major limitations: both datasets are US-sourced proxies, the two axes are observed marginally rather than jointly, the DDI analysis is underpowered (55–77 images per Fitzpatrick test group), the correlation is not inferential, model comparisons confound architecture with pretraining scale, and balanced accuracy is not chance-normalized across tasks with different class counts.

Review complete

Assessment at a glance

medical imaging AI (dermatology, computer vision)

5

risk flags identified

● high 0

● medium 3

● low 2

Reproducibility readinesshigh
Code & data availableyes
Review confidencehigh
AI text signal0/20 passages flagged
Deep research viableCode-reproducibleNeeds GPU

5 strengths · 5 weaknesses · 5 author questions

AI text signal = Binoculars zero-shot detector score over 20 sampled passages (Fast-DetectGPT co-reported) — absence does not prove human authorship, and a flag does not imply misconduct.

Levels reflect verification complexity — not a quality score. Evolve never rates your paper.

Key claims under review

  • In the evaluated settings, disease-distribution shift contributes more to the dermatology-AI generalization gap than skin tone: the cancer baseline drops from 0.62 to 0.21 balanced accuracy on SCIN while the within-disease DDI tone gap is only 0.10–0.18 and directionally inconsistent.
  • The distribution-shift collapse is representational rather than a missing-output-label artifact: cancer-specialized features fall from +0.42 to +0.06 kNN purity lift on SCIN while dermatology-pretrained features retain up to +0.23 (DermLIP).
  • Recoverable performance under cheap adaptation is bounded by pre-existing representation quality: ten labeled examples per SCIN category nearly match full-probe performance for dermatology foundation models (DermLIP 0.41 vs 0.36), and SCIN purity lift correlates with full-probe accuracy at r=0.90 (n=4, descriptive).

Strengths

  • Clean two-axis isolation design with a strictly identical downstream pipeline

    DDI (656 images, binary malignant/benign, Fitzpatrick groups) holds diagnosis broadly fixed for the tone axis while SCIN (6,517 images, 3,061 patients, seven clinical categories) isolates distribution shift; Section 3.3's comparability paragraph pins the same patient-level split (seed 42), standardization, probe hyperparameters, k=10 cosine purity, and bootstrap procedure across all four encoders.

  • Label-free refutation of the missing-labels objection

    The kNN purity lift over a chance floor (Σpᵢ², k=10, cosine) shows the cancer baseline collapsing from +0.42 in-domain to +0.06 on SCIN while DermLIP retains +0.23 (Fig. 2) — geometric evidence that the failure is representational, not an artifact of disjoint label spaces (Section 4.2).

  • Unusually candid, specific limitations section

  • Compute-light, actionable few-shot result

  • Reproducibility scaffolding is concrete

Weaknesses

  • The headline decomposition compares quantities on different scales

  • Tone × disease interaction is untested yet the deployment guidance presupposes it

  • Specialization is confounded with architecture, objective, and pretraining scale

  • Tone conclusions rest on underpowered cells with wide intervals

  • A numerical multiplier overstatement and dimensionality caveat

Full Review Report

$1.99 · one-time

Unlock the complete preliminary analysis Evolve produced for this paper.

Report preview

Scope & Claims

The paper asks a confounding-question audit: when dermatology AI trained on light-skinned, cancer-focused archives (HAM10000, ISIC 2019) fails in resource-constrained settings (RCS), is the culprit skin tone or disease distribution? Three claims are advanced. (1) Distribution shift dominates: the cancer baseline falls from 0.62 to 0.21 balanced accuracy on SCIN while DDI tone gaps are 0.10–0.18 with no consistent direction (Table 2). (2) The collapse is representational, not a label-space artifact: kNN purity lift drops from +0.42 to +0.06 for the cancer baseline while DermLIP retains +0.23 (Fig. 2, Section 4.2). (3) Adaptation is bounded by representation quality: ten labels per category nearly match full probes (Table 3), and SCIN purity correlates with recoverable accuracy at r=0.90 (n=4, explicitly descriptive). This is a deliberate open replication-and-extension of Rikhye et al.'s proprietary finding, pushed to an extreme cancer-to-non-neoplastic shift.

The remaining sections cover Methodology Assessment, Statistical Evidence, Results & Reproducibility, Limitations & Risks, and Verdict & Recommendations.

  • All 5 strengths & 5 weaknesses, analyzed in detail
  • 5 risk flags with severity, section & reviewer questions
  • Methods & statistical evidence assessment
  • 5 questions a peer reviewer would ask
  • Full six-dimension evaluation report & recommendations

One-time purchase · this paper only

One-time purchase, this paper only. AI-generated preliminary analysis — not peer review.

Frequently asked questions

Does this paper say skin tone doesn't matter in dermatology AI?

No. The authors measure a real but small within-disease tone effect — a max–min gap of 0.10–0.18 balanced accuracy across Fitzpatrick groups on the DDI dataset — and explicitly state that tone-diverse data remain important for fairness auditing. Their claim is about which factor dominates the deployment gap in the settings studied (disease-distribution shift does), not that tone effects are absent. They also caution their tone analysis is underpowered, with only 55–77 test images per skin-tone group.

What makes dermatology AI models fail outside their training data, according to this study?

The study argues that unfamiliar diseases hurt far more than unfamiliar skin tones. A model fine-tuned on cancer images (HAM10000, ISIC 2019) fell from 0.62 to 0.21 balanced accuracy when probed on non-cancer skin conditions (SCIN), while the skin-tone gap on matched diagnoses (DDI) was only 0.10–0.18 with no consistent direction. A label-free analysis shows the cancer model's internal features barely separate unfamiliar conditions (kNN purity lift +0.06 versus +0.23 for dermatology foundation models), meaning the failure is representational, not just a missing output label.

How much labeled data is needed to adapt a dermatology foundation model to local conditions?

In this paper's experiments, a simple linear probe trained on frozen features with roughly ten labeled examples per condition category nearly matched or exceeded probes trained on all available data for the dermatology foundation models DermLIP (0.41 vs 0.36 balanced accuracy) and MONET (0.39 vs 0.34) on the SCIN dataset. The adaptation runs on CPU. The authors frame this as a promising but not yet validated recipe for resource-constrained clinics; a cancer-specialized model could not be rescued this way (0.19).

Can I reproduce this study, and is the code available?

Yes, that is an explicit design goal. The paper uses only public datasets (HAM10000, ISIC 2019, DDI, SCIN), releases code and the evaluation protocol at github.com/Nirajan995/dermatology-generalization-gap, states fixed splits (seed 42) and bootstrap settings, and reports that all experiments ran on free-tier compute — a single Kaggle T4 GPU session per stage plus CPU-only downstream analysis completing in minutes.

About this review

This is an AI-generated preliminary review by Evolve.Pub, produced from the openly available text of the paper. It is not peer review and does not represent the authors' views. The canonical record of the paper is at the publisher link above.

  • Figure 1 is present only as embedded text labels in the extraction (no graphical content), but it carries no quantitative values, so no analysis depends on it.
  • Per-Fitzpatrick-group DDI accuracies are not reported anywhere in the text (only max–min gaps with CIs), so the claimed inconsistency of gap direction could not be independently verified from the provided text; the extraction is otherwise complete through reference 24.

Go deeper on this paper

Wrote a paper? Stress-test it before reviewers do.

Upload your manuscript for the same structured scrutiny — reasoning, statistics, evidence, figures, and reproducibility.

Scan your paper
Disease Burden over Skin Tone: Decomposing the Dermatology-AI Generalization Gap | Evolve.Pub